Malignant neoplasm of acoustic nerve
ICD-10 C72.4 is a billable code used to indicate a diagnosis of malignant neoplasm of acoustic nerve.
C72.4 refers to a malignant neoplasm of the acoustic nerve, which is part of the cranial nerves responsible for hearing and balance. This neoplasm can arise from Schwann cells, leading to vestibular schwannomas (also known as acoustic neuromas) that may exhibit malignant characteristics. Symptoms often include hearing loss, tinnitus, and balance disturbances. Imaging studies, particularly MRI, are crucial for diagnosis, as they provide detailed visualization of the tumor's size, location, and relationship to surrounding structures. Molecular markers, such as mutations in the NF2 gene, may be investigated to understand the tumor's biology and guide treatment decisions. Neurological function can be significantly impacted, necessitating a multidisciplinary approach for management, including surgical intervention, radiation therapy, and rehabilitation services.
Complete audiological assessments, imaging reports, and surgical notes.
Patients presenting with unilateral hearing loss, tinnitus, or balance issues.
Ensure clear documentation of symptoms and imaging findings to support the diagnosis.
Detailed operative reports, pathology results, and post-operative follow-up notes.
Surgical intervention for tumor resection or management of complications.
Document the extent of resection and any neurological deficits post-surgery.
Used when a patient undergoes surgical resection of a malignant neoplasm of the acoustic nerve.
Operative report detailing the procedure, findings, and any complications.
Neurosurgeons must document the extent of tumor resection and any neurological outcomes.
MRI is the preferred imaging modality for diagnosing malignant neoplasms of the acoustic nerve, as it provides detailed images of the tumor and its relationship to surrounding structures.
